Exosome Diagnostics Company
Exosome Diagnostics develops and commercializes blood-based cancer molecular diagnostics for patient stratification and disease monitoring.
Technology:
Genetic Test & Molecular Diagnostics
Industry:
Deep Diagnostics
Headquarters:
New York, New York, United States
Founded Date:
01.01.2008
Funding Status:
M&A
Estimated Revenue:
$10M to $50M
Register and Claim Ownership